Evidence map›Paper›PMID 36456864›Full record

ArticleDiabetologia2023

Distinct subcellular localisation of intramyocellular lipids and reduced PKCε/PKCθ activity preserve muscle insulin sensitivity in exercise-trained mice.

Rafael C Gaspar, Kun Lyu, Brandon T Hubbard, Brooks P Leitner, Panu K Luukkonen, Sandro M Hirabara, Ikki Sakuma, Ali Nasiri, Dongyan Zhang, Mario Kahn and 5 more

Open access · hybridAbstract read
In one paragraph

Article in Diabetologia, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 24 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. American journal of physiology. Endocrinology and metabolism · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 2 countries.

Rafael C GasparDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
Kun LyuDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
Brandon T HubbardDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
Brooks P LeitnerDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
Panu K LuukkonenDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
Sandro M HirabaraDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
Ikki SakumaDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
Ali NasiriDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
Dongyan ZhangDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
Mario KahnDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
Gary W ClineDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
José Rodrigo PauliSchool of Applied Science, University of Campinas, Limeira, SP, Brazil.
Rachel J PerryDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
Kitt F PetersenDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
Gerald I ShulmanDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT, USA. gerald.shulman@yale.edu.
Yale University · USUniversidade Estadual de Campinas (UNICAMP) · BR

Funding

Yale Diabetes Research CenterP30DK045735 · NIDDK · YALE UNIVERSITY · PI Kevan C Herold, GERALD I SHULMAN · 1993 to 2026
$44.0M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007205 · NIGMS · YALE UNIVERSITY · PI KAZMIERCZAK, BARBARA I · 1985 to 2019
$42.9M
Yale Liver CenterP30DK034989 · NIDDK · YALE UNIVERSITY · PI MICHAEL H NATHANSON · 1986 to 2026
$31.1M
Effects of Hepatic Acetyl-CoA Carboxylase Inhibition on NAFLD and Hepatic Insulin ResistanceR01DK113984 · NIDDK · YALE UNIVERSITY · PI SHULMAN, GERALD I · 2017 to 2021
$3.7M
Development of Controlled Release Mitochondrial Protonophore (CRMP) as a Novel Treatment for Type-2 Diabetes and Non-Alcoholic Steatohepatitis in Dysmetabolic Non-Human PrimatesR01DK119968 · NIDDK · YALE UNIVERSITY · PI SHULMAN, GERALD I · 2019 to 2024
$2.7M
Targeting hepatic mitochondrial oxidation to treat NAFLD, NASH and type 2 diabetesR01DK135645 · NIDDK · YALE UNIVERSITY · PI KITT F PETERSEN, GERALD I SHULMAN · 2024 to 2026
$2.1M
Vesicle Translocation and the Metabolic SyndromeR01DK092661 · NIDDK · YALE UNIVERSITY · PI BOGAN, JONATHAN · 2012 to 2018
$2.0M
Glucagon Regulation of Hepatic Mitochondrial Activity and Glucose Metabolism by InsP3R-1R01DK116774 · NIDDK · YALE UNIVERSITY · PI SHULMAN, GERALD I · 2018 to 2021
$1.7M
Cellular mechanisms for increased gluconeogenesis in type 2 diabetes mellitus: the role of lipid induced pyruvate carboxylase acetylation in increasing hepatic gluconeogenic capacity.I01BX000901 · VA · VA CONNECTICUT HEALTHCARE SYSTEM · PI SAMUEL, VARMAN T · 2012 to 2020
–
BLRD VA I01 BX000901NIDDK NIH HHS P30 DK034989NIDDK NIH HHS P30 DK045735NIDDK NIH HHS R01 DK092661NIDDK NIH HHS R01 DK113984NIDDK NIH HHS R01 DK116774NIDDK NIH HHS R01 DK119968NIDDK NIH HHS R01 DK135645NIGMS NIH HHS T32 GM007205
6 · The paper itself

Abstract

aims/hypothesisAthletes exhibit increased muscle insulin sensitivity, despite increased intramuscular triacylglycerol content. This phenomenon has been coined the 'athlete's paradox' and is poorly understood. Recent findings suggest that the subcellular distribution of sn-1,2-diacylglycerols (DAGs) in the plasma membrane leading to activation of novel protein kinase Cs (PKCs) is a crucial pathway to inducing insulin resistance. Here, we hypothesised that regular aerobic exercise would preserve muscle insulin sensitivity by preventing increases in plasma membrane sn-1,2-DAGs and activation of PKCε and PKCθ despite promoting increases in muscle triacylglycerol content.

methodsC57BL/6J mice were allocated to three groups (regular chow feeding [RC]; high-fat diet feeding [HFD]; RC feeding and running wheel exercise [RC-EXE]). We used a novel LC-MS/MS/cellular fractionation method to assess DAG stereoisomers in five subcellular compartments (plasma membrane [PM], endoplasmic reticulum, mitochondria, lipid droplets and cytosol) in the skeletal muscle.

resultsWe found that the HFD group had a greater content of sn-DAGs and ceramides in multiple subcellular compartments compared with the RC mice, which was associated with an increase in PKCε and PKCθ translocation. However, the RC-EXE mice showed, of particular note, a reduction in PM sn-1,2-DAG and ceramide content when compared with HFD mice. Consistent with the PM sn-1,2-DAG-novel PKC hypothesis, we observed an increase in phosphorylation of threonine CONCLUSIONS/

interpretationThese results demonstrate that lower PKCθ/PKCε activity and sn-1,2-DAG content, especially in the PM compartment, can explain the preserved muscle insulin sensitivity in RC-EXE mice.

Indexed as

Insulin ResistanceAnimalsCeramidesChromatography, LiquidInsulinMiceMice, Inbred C57BLMuscle, SkeletalPhosphatidylinositol 3-KinasesProtein Kinase C-epsilonProtein Kinase C-thetaTandem Mass SpectrometryTriglyceridesCeramidesInsulinPhosphatidylinositol 3-KinasesProtein Kinase C-epsilonProtein Kinase C-thetaTriglyceridesAthlete’s paradoxInsulin resistancePhysical exercisePKCεPKCθSkeletal muscle

Identifiers

PMID36456864
PMCPMC11194860
OpenAlexW4310516408

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.